Nuclear Medicine

Neuroendocrine Tumors

Questions discussed in this category

Can PRRT be used in a patient with a GI neuroendocrine tumor and estimated GFR of less than 30?

1 Answer available

Papers discussed in this category

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2005-01

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.

J. Nucl. Med.,

NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of Lu-DOTATATE Peptide Receptor Radionuclide Therapy.

Neuroendocrinology, 2017 Apr 13

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasia: Peptide Receptor Radionuclide Therapy with Radiolabeled Somatostatin Analogues.

Related Topics in Nuclear Medicine